Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hammerness

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Expert Opinion on Drug Safety|July 14, 2005
Safety review of kava (Piper methysticum) by the Natural Standard Research CollaborationCatherine Ulbricht, Ethan Basch, Heather Boon, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|September 30, 2023
Effectiveness of collaborative tele-mental health care for children with attention deficit hyperactivity disorder in United Arab EmiratesAmmar Albanna, Karina Soubra, Deena Alhashmi, et al.
Psychosomatics|July 2, 2003
St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatristPaul Hammerness, Ethan Basch, Catherine Ulbricht, et al.
Journal of Herbal Pharmacotherapy|July 28, 2004
Kava monograph: a clinical decision support toolEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.
Complementary Therapies in Medicine|December 13, 2005
Guggul for hyperlipidemia: a review by the Natural Standard Research CollaborationCatherine Ulbricht, Ethan Basch, Philippe Szapary, et al.
Journal of Child and Adolescent Psychopharmacology|November 3, 2009
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokineticsPaul Hammerness, Anna Georgiopoulos, Robert L Doyle, et al.
The Journal of Pediatrics|August 11, 2012
Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidatePaul Hammerness, Gagan Joshi, Robert Doyle, et al.
Biological Psychiatry|December 24, 2005
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric Mick, Craig Surman, et al.
Journal of Herbal Pharmacotherapy|July 28, 2004
Shark cartilage monograph: a clinical decision support toolPaul Hammerness, Catherine Ulbricht, Ernie Paul Barrette, et al.
The Israel Journal of Psychiatry and Related Sciences|June 2, 2012
A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulationJanet Wozniak, Atilla Gönenç, Joseph Biederman, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Expert Opinion on Drug Safety|July 14, 2005
Safety review of kava (Piper methysticum) by the Natural Standard Research CollaborationCatherine Ulbricht, Ethan Basch, Heather Boon, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|September 30, 2023
Effectiveness of collaborative tele-mental health care for children with attention deficit hyperactivity disorder in United Arab EmiratesAmmar Albanna, Karina Soubra, Deena Alhashmi, et al.
Psychosomatics|July 2, 2003
St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatristPaul Hammerness, Ethan Basch, Catherine Ulbricht, et al.
Journal of Herbal Pharmacotherapy|July 28, 2004
Kava monograph: a clinical decision support toolEthan Basch, Catherine Ulbricht, Paul Hammerness, et al.
Complementary Therapies in Medicine|December 13, 2005
Guggul for hyperlipidemia: a review by the Natural Standard Research CollaborationCatherine Ulbricht, Ethan Basch, Philippe Szapary, et al.
Journal of Child and Adolescent Psychopharmacology|November 3, 2009
An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokineticsPaul Hammerness, Anna Georgiopoulos, Robert L Doyle, et al.
The Journal of Pediatrics|August 11, 2012
Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidatePaul Hammerness, Gagan Joshi, Robert Doyle, et al.
Biological Psychiatry|December 24, 2005
A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric Mick, Craig Surman, et al.
Journal of Herbal Pharmacotherapy|July 28, 2004
Shark cartilage monograph: a clinical decision support toolPaul Hammerness, Catherine Ulbricht, Ernie Paul Barrette, et al.
The Israel Journal of Psychiatry and Related Sciences|June 2, 2012
A magnetic resonance spectroscopy study of the anterior cingulate cortex in youth with emotional dysregulationJanet Wozniak, Atilla Gönenç, Joseph Biederman, et al.
Pageof 7